Skip to content
TrialScanner

NCT06828055

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

Phase 2CompletedVKTXLead

Registry record

Lead sponsor
Viking Therapeutics, Inc.
Conditions
Weight Loss
Primary completion
Jun 24, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06828055 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06828055: VK2735 for Weight Management... | TrialScanner